Quick answer: when you buy research peptides online, the vendor’s analytical rigor matters more than the price. Look for third-party HPLC and mass-spec testing on every batch, a public COA library, cold-chain shipping, and a real company you can reach.
Quick answer: a Certificate of Analysis (COA) is the document that states what is actually in the vial. A useful research COA confirms identity by mass spectrometry, purity by HPLC, and carries the batch number that ties the report to the vial on your bench.
Quick answer: store lyophilized peptides sealed at -20°C, protected from light and moisture. Once reconstituted, keep the working solution at 2 to 8°C, split it into single-use aliquots, and avoid repeated freeze-thaw cycles.
Quick answer: CJC-1295 without DAC is a GHRH analog and ipamorelin is a selective GHRP. In preclinical research they are studied together because they act on two different receptors on the same pituitary cells, which is why combined exposure produces a larger, more pulsatile growth-hormone response in laboratory models than either alone.
Quick answer: HPLC measures purity (how much of the sample is the target compound); mass spectrometry confirms identity (whether the compound is what the label says). A complete COA reports both, because a sample can be pure and still be the wrong molecule.
Quick answer: in the published Phase 2 trial of retatrutide (GLP-3 RT), the most common adverse events were gastrointestinal: nausea, diarrhea, vomiting, and constipation. They were dose-related, mostly mild to moderate, and clustered during dose escalation. A dose-dependent increase in heart rate was also reported, peaking early and declining over the study.
Quick answer: semaglutide activates one receptor (GLP-1), tirzepatide activates two (GIP and GLP-1), and retatrutide (GLP-3 RT) activates three (GIP, GLP-1, and glucagon). In published trials, each added receptor has been associated with larger weight reduction, with the glucagon component adding an energy-expenditure mechanism the other two lack.
Quick answer: GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied mainly in dermal, wound-model, and gene-expression research. Working solutions are prepared from lyophilized powder by weight to volume, and the blue color of a reconstituted vial comes from the copper complex.
Quick answer: concentration equals milligrams of peptide divided by milliliters of solvent added. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL, which is 5,000 mcg/mL, or 50 mcg per unit on a standard 100-unit (1 mL) syringe.
Quick answer: a BPC-157 + TB-500 blend vial contains two peptides at a fixed ratio, so the concentration of each is calculated separately from the same volume of solvent. Divide each peptide’s milligrams by the milliliters added to get its mg/mL, then use the calculator to convert a target amount of either peptide into a syringe draw.